Could a gut pill help type 1 diabetes? small trial explores Butyrate's potential
NCT ID NCT03999853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested whether a colon-targeted butyrate tablet (BKR-017) could help people with type 1 diabetes improve insulin sensitivity and lower triglycerides. Six adults with type 1 diabetes took the tablets for 28 days alongside their usual care. The goal was to see if this supplement could be a helpful add-on therapy, not a replacement for insulin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new sensor track blood sugar with pinpoint accuracy?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Carb showdown: which diet best controls type 1 diabetes?
- Morning workout may burn more fat and stabilize blood sugar in type 1 diabetes
- Could a simple sugar help people with type 1 diabetes exercise safely?
- New study asks: is this glucose monitor a Game-Changer for diabetes?